Novartis drug hunters leverage machine learning and automation to power a faster, smarter way to navigate to new drugs.

Targeting inflammation to fight cancer is a new approach with a long history.

A new compound aims to attack dangerous antibiotic-resistant bacteria.

John Hadcock’s wife Laura gave him an ultimatum: Run the energy out of Sunny, the new puppy, or take her back to the breeder. So Hadcock started running. On his first trip out, he had to stop half a mile in.

Gervais Tougas shares his experience working on a Novartis task force dedicated to fighting the COVID-19 pandemic.

A reversal in thinking about the reversibility of liver damage is changing the field of hepatology.